Keyphrases
COVID-19
100%
Clinical Characterization
31%
Zika Virus
28%
Aedes Albopictus
25%
China
22%
Transmission Risk
21%
Emerging Infections
19%
Severe Acute Respiratory Syndrome
19%
Parainfectious
18%
Autoantibody Response
18%
Cytokine Response
18%
Brain Injury
18%
Vector Transmission
18%
El Nio
18%
Global Risk
18%
Risk Model
18%
Virus
16%
Pollination
12%
Pollination Network
12%
Zika Virus Transmission
11%
Future Climate
11%
South America
10%
Temperate Region
10%
Epidemiological Surveillance
9%
Gene Targeting
9%
Spike Gene
9%
Failure Data
9%
SARS-CoV-2 Omicron
9%
Omicron Variant
9%
Coronavirus Disease (COVID)
9%
Climatic Control
9%
COVID-19 Cases
9%
SARS-CoV-2 Transmission
9%
Large-scale Phenotyping
9%
Pollination Services
9%
Long Coronavirus Disease
9%
Evolutionary Stability
9%
Lethal Temperature
9%
Daily Use
9%
Prognostic Model
9%
Inflammatory Mediators
9%
Lateral Flow Device
9%
Randomized Controlled Non-inferiority Trial
9%
Vaccination
9%
Delay Differential Equation Model
9%
Dengue Transmission
9%
Neisseria
9%
Self-isolation
9%
Temperate Climate
9%
Mutualistic Networks
9%
Medicine and Dentistry
COVID-19
58%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Infection
32%
Cytokine
18%
Autoantibodies
18%
Zika Virus
18%
Brain Injury
18%
Blood Donor
9%
Prospective Cohort Study
9%
Neisseriaceae Infection
9%
Systematic Review
9%
Noninferiority Trial
9%
Deterioration
9%
Gonorrhea
9%
Population Exposure
9%
Neutralizing Antibody
9%
4 Iodo 2,5 Dimethoxyamphetamine
9%
Polymerase
9%
Interstitial Lung Disease
9%
Virus
8%
Virus Genome
7%
Neurological Complication
6%
Receptor Binding
5%